share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD

Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD

诺瓦瓦克斯医药 | 4:持股变动声明-董事 DOUGLAS RICHARD
美股SEC公告 ·  06/15 04:16

Moomoo AI 已提取核心信息

On June 12, 2024, Richard Douglas, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, which is typically related to options or warrants being converted into stock. Following this acquisition, Douglas directly holds a total of 43,920 shares in Novavax. The transaction reflects a continued investment in the company by an individual closely associated with it.
On June 12, 2024, Richard Douglas, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost. This transaction was categorized as an exercise or conversion of derivative security, which is typically related to options or warrants being converted into stock. Following this acquisition, Douglas directly holds a total of 43,920 shares in Novavax. The transaction reflects a continued investment in the company by an individual closely associated with it.
2024年6月12日,诺瓦瓦克斯医药公司[NVAX]的关联人Richard Douglas以零成本完成购买公司普通股的交易,共购买了6,670股。此项交易被归类为衍生证券的行权或转换,通常涉及期权或权证转换为股票。在此次收购之后,Douglas在诺瓦瓦克斯医药公司拥有直接持有43,920股。这项交易反映了一个与公司有密切关联的个人对公司的持续投资。
2024年6月12日,诺瓦瓦克斯医药公司[NVAX]的关联人Richard Douglas以零成本完成购买公司普通股的交易,共购买了6,670股。此项交易被归类为衍生证券的行权或转换,通常涉及期权或权证转换为股票。在此次收购之后,Douglas在诺瓦瓦克斯医药公司拥有直接持有43,920股。这项交易反映了一个与公司有密切关联的个人对公司的持续投资。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息